Well here's a thought. on the back of the 4C, the price dropped ~10% to about $0.38 and 10 million shares traded in early trading, so, ignoring the intermediate trades, that's about $4M and 10% of that is $400K of losses sustained by the sellers. Then the shares rose back to about $0.41. So those who bought at $0.38 notionally made $0.03 or just a tick under 8%.Spot the odd one out!
Did you spot the outlier?
- Is Brainchip meeting development timelines with the development of it’s technology?
- Does the technology work in terms of efficiency, speed and fit for purpose?
- Are any really big companies singing the praises of Akida and our IP?
- Are any big foundries lining up production of chips including Brainchip’s technology?
- Is the company pulling out all stops to present our products at relevant field events?
- Is our technology well protected by patents?
- Do we have any serious competition?
- Do we have the talented staff to continue development and sales?
- Is Brainchip’s long-term success assured (in your opinion and based on the evidence available)?
- Is the share price booming to reflect the answers to the above?
Now a few bonus questions. These ones might be a bit harder.
Remember, wealth flows to the patient.
- Can the company control what the share price is doing?
- When will the company start to earn some serious income?
- When will the next partnership or customer be announced?
Deena
So that's about $320K for not much work, better than being four retired US admirals - come back Tirath - all is forgiven.